Jane Street
ADIL

Jane Street’s Adial Pharmaceuticals ADIL Stock Holding History

Jane Street’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,874
Closed -$26.8K – 11422
2025
Q4 		$26.8K Buy
4,874
+4,380
+887% +$35.5K ﹤0.01% 10667
2025
Q3 		$4.36K Sell
494
-500
-50% -$4.87K ﹤0.01% 10613
2025
Q2 		$7.51K Buy
+994
New +$15K ﹤0.01% 9417
2022
Q3 		– Sell
-22
Closed -$19K – 9608
2022
Q2 		$19K Buy
+22
New +$19.9K ﹤0.01% 9171
2019
Q2 		– Sell
-49
Closed -$105K – 5060
2019
Q1 		$105K Buy
+49
New +$146K ﹤0.01% 4767

Other funds holding ADIL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Jane Street's ADIL Position: Q1 2026 in Review

Jane Street sold out of Adial Pharmaceuticals (ADIL) in Q1 2026, closing a stake of 4,874 shares — an estimated $26.8K sold.

Jane Street first reported a position in ADIL in Q1 2019 and held it in 5 quarters. The position peaked at $105K in Q1 2019. 14 funds tracked by Wall St. Rank hold ADIL as of Q1 2026.

  • Jane Street reported no remaining Adial Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 4,874 Adial Pharmaceuticals shares in Q1 2026, an estimated $26.8K.
  • Jane Street first reported a position in Adial Pharmaceuticals in Q1 2019 and held it in 5 quarters.
  • Jane Street's Adial Pharmaceuticals position peaked at $105K in Q1 2019.
  • 14 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.